---

---

symbols : TEVJF   

save search

---

HIV Drugs Market to Reach $51.1 Billion, Globally, by 2032 at 4.5% CAGR: Allied Market Research
Published: 2023-11-17 (Crawled : 16:00) - prnewswire.com
JNJ | News | $147.885 -1.12% 1.5M |

Health Technology

| 0.1% | O: 0.78% H: 0.0% C: 0.0%
BMY | $48.795 -0.4% 1.5M |

Health Technology

| -3.64% | O: 0.69% H: 0.06% C: -0.68%
ABBV | News | $168.635 -0.53% 440K |

Health Technology

| 22.61% | O: 0.01% H: 0.0% C: 0.0%
GILD | $66.85 -0.27% 1M |

Health Technology

| -10.05% | O: 0.5% H: 0.82% C: 0.75%
reach research hiv market

---

Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S.
Published: 2023-11-17 (Crawled : 16:00) - biospace.com/
TEVA | $13.055 0.35% 490K |

Health Technology

| 48.52% | O: 0.91% H: 2.6% C: 2.38%
HALO M | $39.09 0.31% 27K |

Health Technology

| -1.39% | O: 0.94% H: 1.8% C: 0.1%
forteo approval teva

---

Digital Dose Inhaler Market Set for Remarkable Growth, Estimated at $104.3 Billion by 2033
Published: 2023-11-16 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $19.54 2.6K |

Health Technology

| 14.6% | O: 0.59% H: 0.0% C: 0.0%
AZNCF | News | $140.3 1.5K |

Health Technology

| 12.1% | O: -2.16% H: 4.44% C: 2.2%
GSK | News | $40.82 -1.02% 230K |

Health Technology

| 19.64% | O: -0.15% H: 0.23% C: 0.06%
MMM | $92.6 -0.43% 510K |

Producer Manufacturing

| -3.95% | O: -0.96% H: 0.58% C: -0.19%
AZN | News | $70.905 0.08% 1.6M |

Health Technology

| 12.23% | O: 0.46% H: 0.71% C: 0.6%
set market

---

Global Epinephrine Markets, 2017-2022, 2022-2027F, 2032F: Product Innovation Drives Growth, Rising Prevalence of Chronic Respiratory Diseases Driving Demand
Published: 2023-11-14 (Crawled : 15:30) - prnewswire.com
VTRS | News A | $11.29 -0.62% 580K |

Health Technology

| 26.93% | O: 1.68% H: 2.09% C: 1.32%
BHC | $8.53 100K |

Health Technology

| 30.63% | O: 3.37% H: 2.07% C: 0.59%
ABT | News | $106.1 -1.39% 810K |

Health Technology

| 12.65% | O: 0.94% H: 0.0% C: 0.0%
SNY | News | $47.27 -0.88% 130K |

Health Technology

| 3.7% | O: 0.68% H: 0.0% C: 0.0%
respiratory innovation global epinephrine

---

Alvotech and JAMP Pharma Announce Receipt of Marketing Authorization for Jamteki (AVT04), the First Biosimilar of Stelara® (ustekinumab)
Published: 2023-11-14 (Crawled : 12:00) - globenewswire.com
ALVO | $13.585 1.38% 110K |

n/a

| 48.56% | O: 0.33% H: 3.87% C: -0.55%
JNJ | News | $147.885 -1.12% 1.5M |

Health Technology

| 1.52% | O: 0.17% H: 0.0% C: 0.0%
KMDA | $5.1 1.1K |

Health Technology

| 8.35% | O: 0.21% H: 1.67% C: 1.25%
avt04 stelara pharma biosimilar authorization

---

Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program
Published: 2023-11-13 (Crawled : 13:30) - biospace.com/
TEVA | $13.055 0.35% 490K |

Health Technology

| 49.88% | O: -0.92% H: 4.53% C: 2.56%
JNJ | News | $147.885 -1.12% 1.5M |

Health Technology

| 1.01% | O: -0.5% H: 0.0% C: 0.0%
RPRX | $27.76 -0.22% 170K |

Health Technology

| 2.2% | O: -0.44% H: 0.59% C: 0.04%
pharma royalty teva program

---

Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program
Published: 2023-11-13 (Crawled : 13:00) - globenewswire.com
JNJ | News | $147.885 -1.12% 1.5M |

Health Technology

| 1.01% | O: -0.5% H: 0.0% C: 0.0%
RPRX | $27.76 -0.22% 170K |

Health Technology

| 2.2% | O: -0.44% H: 0.59% C: 0.04%
pharma royalty teva program

---

Challenges in Transparency and Control Hamper Merchant API Market Growth Despite Pharmaceutical Industry Expansion
Published: 2023-11-10 (Crawled : 00:20) - prnewswire.com
SNY | News | $47.27 -0.88% 130K |

Health Technology

| Email alert Add to watchlist
LZAGY | $57.57 93K |

Professional, Scientific, and T...

| Email alert Add to watchlist
SNYNF | News | $94.25 480 |

Health Technology

| Email alert Add to watchlist
TEVJF | News | $12.37 -24.22% 380 |

Health Technology

| Email alert Add to watchlist
LZAGF | $558.779 23 |

Health Technology

| Email alert Add to watchlist
TMO | News | $579.55 0.86% 350K |

Health Technology

| Email alert Add to watchlist
control expansion growth market

---

STADA and Alvotech receive positive CHMP opinion for Europe’s first ustekinumab biosimilar to Stelara
Published: 2023-11-10 (Crawled : 14:30) - globenewswire.com
ALVO | $13.585 1.38% 110K |

n/a

| 54.2% | O: 0.12% H: 7.18% C: 3.56%
KMDA | $5.1 1.1K |

Health Technology

| 11.61% | O: -0.22% H: 0.86% C: 0.86%
biosimilar chmp positive stelara

---

Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
Published: 2023-11-08 (Crawled : 14:00) - biospace.com/
SNYNF | News | $94.25 480 |

Health Technology

| 3.59% | O: -0.33% H: 0.0% C: 0.0%
TEVA | $13.055 0.35% 490K |

Health Technology

| 43.92% | O: 2.54% H: 3.23% C: -1.29%
SNY | News | $47.27 -0.88% 130K |

Health Technology

| 4.42% | O: 1.62% H: 0.0% C: 0.0%
revenue teva financial results

---

Alvotech to Present at the Jefferies 2023 London Healthcare Conference
Published: 2023-11-07 (Crawled : 13:00) - globenewswire.com
ALVO | $13.585 1.38% 110K |

n/a

| 55.63% | O: -0.12% H: 2.33% C: 0.47%
KMDA | $5.1 1.1K |

Health Technology

| 9.03% | O: -0.42% H: 0.42% C: 0.21%
conference

---

Clonidine Micropellet Epidural Injections Fuel Growth in Global Sciatica Treatment Market
Published: 2023-11-01 (Crawled : 23:00) - prnewswire.com
VTRS | News A | $11.29 -0.62% 580K |

Health Technology

| 27.35% | O: 0.67% H: 0.22% C: -0.56%
NVS | News | $98.03 0.77% 650K |

Health Technology

| 4.88% | O: -1.09% H: 1.03% C: 0.91%
JNJ | News | $147.885 -1.12% 1.5M |

Health Technology

| 0.46% | O: -0.89% H: 0.0% C: 0.0%
SNY | News | $47.27 -0.88% 130K |

Health Technology

| 3.11% | O: 3.0% H: 0.0% C: 0.0%
treatment global growth market

---

Muscle Wasting Disorders Market Predicted to Reach USD 45.4 Billion by 2031, Garnering 15.1% CAGR: TMR Report
Published: 2023-10-30 (Crawled : 15:30) - prnewswire.com
NVS | News | $98.03 0.77% 650K |

Health Technology

| 7.14% | O: 1.69% H: 0.25% C: -0.07%
SRPT | $117.98 0.73% 13K |

Health Technology

| 9.63% | O: 1.05% H: 1.86% C: -0.28%
PTCT | News S | $25.825 1.63% 43K |

Health Technology

| 40.33% | O: 0.38% H: 5.49% C: 0.86%
IONS | $42.58 1.77% 70K |

Health Technology

| -5.02% | O: -0.16% H: 1.58% C: 0.05%
report reach disorders market

---

Data Logger Market is Anticipated to Reach US$ 12 billion by 2031 Says, Transparency Market Research
Published: 2023-10-30 (Crawled : 14:30) - prnewswire.com
NVS | News | $98.03 0.77% 650K |

Health Technology

| 7.14% | O: 1.69% H: 0.25% C: -0.07%
SRPT | $117.98 0.73% 13K |

Health Technology

| 9.63% | O: 1.05% H: 1.86% C: -0.28%
PTCT | News S | $25.825 1.63% 43K |

Health Technology

| 40.33% | O: 0.38% H: 5.49% C: 0.86%
IONS | $42.58 1.77% 70K |

Health Technology

| -5.02% | O: -0.16% H: 1.58% C: 0.05%
reach research market

---

Increasing Prevalence of Laryngeal Cancer Fuels Growth in Laryngeal Cancer Therapeutics Market
Published: 2023-10-27 (Crawled : 02:00) - prnewswire.com
SNYNF | News | $94.25 480 |

Health Technology

| -10.45% | O: -18.18% H: 0.0% C: 0.0%
AZNCF | News | $140.3 1.5K |

Health Technology

| 11.99% | O: -1.1% H: 0.18% C: -1.98%
SNY | News | $47.27 -0.88% 130K |

Health Technology

| -11.44% | O: -15.73% H: 0.0% C: 0.0%
AZN | News | $70.905 0.08% 1.6M |

Health Technology

| 11.73% | O: -0.42% H: 0.13% C: -1.99%
AMGN | News | $273.905 0.13% 270K |

Health Technology

| 1.42% | O: -0.28% H: 0.15% C: -2.74%
cancer therapeutics growth market

---

Key Players in Motion Sickness Drugs Market Include GlaxoSmithKline, Novartis, and Teva Pharmaceuticals
Published: 2023-10-27 (Crawled : 01:00) - prnewswire.com
NVSEF | News | $96.0 52K |

Health Technology

| 0.85% | O: -3.68% H: 0.0% C: 0.0%
VTRS | News A | $11.29 -0.62% 580K |

Health Technology

| 26.36% | O: 0.0% H: 0.17% C: -2.45%
PBH | $70.435 -1.1% 4.9K |

Health Technology

| 19.38% | O: -0.28% H: 0.57% C: -1.08%
NVS | News | $98.03 0.77% 650K |

Health Technology

| 4.84% | O: -0.23% H: 0.08% C: -1.92%
GSK | News | $40.82 -1.02% 230K |

Health Technology

| 15.58% | O: -0.7% H: 0.0% C: -2.46%
BAX | $40.745 -0.67% 150K |

Health Technology

| 26.41% | O: 0.71% H: 0.26% C: -1.59%
ABT | News | $106.1 -1.39% 810K |

Health Technology

| 15.33% | O: 1.57% H: 0.6% C: -2.01%
pharmaceuticals teva market

---

Biosimilars market size to increase by USD 42.22 billion | Market driven by the notable price advantage of biosimilars compared to biologics - Technavio
Published: 2023-10-25 (Crawled : 03:00) - prnewswire.com
SNYNF | News | $94.25 480 |

Health Technology

| -8.94% | O: 0.4% H: 1.29% C: 1.29%
VTRS | News A | $11.29 -0.62% 580K |

Health Technology

| 24.7% | O: -0.44% H: 0.33% C: -1.1%
NVS | News | $98.03 0.77% 650K |

Health Technology

| 4.16% | O: 0.64% H: 0.46% C: -0.09%
ABBV | News | $168.635 -0.53% 440K |

Health Technology

| 16.8% | O: 0.65% H: 0.54% C: -0.58%
SNY | News | $47.27 -0.88% 130K |

Health Technology

| -10.17% | O: 1.43% H: 0.64% C: -0.09%
BIIB | $204.4 5.81% 900K |

Health Technology

| -23.37% | O: -0.88% H: 0.34% C: -1.27%
AMGN | News | $273.905 0.13% 270K |

Health Technology

| -0.93% | O: -0.37% H: 0.58% C: -1.07%
advantage market

---

Global Generic Drugs Business Analysis Report 2023-2030: Small-molecule Generic Drugs Account for a Lion's Share, Biosimilars Exhibit Fastest Growth
Published: 2023-10-23 (Crawled : 19:00) - prnewswire.com
ENDPQ | News | $0.0007 -50.0% 1K |

n/a

| -55.56% | O: -44.44% H: 60.0% C: -20.0%
AZNCF | News | $140.3 1.5K |

Health Technology

| 13.37% | O: 1.37% H: 1.36% C: 1.36%
VTRS | News A | $11.29 -0.62% 580K |

Health Technology

| 27.35% | O: 0.45% H: 2.46% C: 1.67%
NVO | News | $126.275 -1.84% 970K |

Health Technology

| 32.45% | O: -0.79% H: 1.41% C: 1.21%
LLY | News | $733.27 -1.67% 470K |

Health Technology

| 26.15% | O: -0.84% H: 0.0% C: 0.0%
BAX | $40.745 -0.67% 150K |

Health Technology

| 24.87% | O: 0.2% H: 0.9% C: -1.05%
ABT | News | $106.1 -1.39% 810K |

Health Technology

| 10.72% | O: -1.82% H: 0.0% C: 0.0%
SNY | News | $47.27 -0.88% 130K |

Health Technology

| -9.48% | O: 0.77% H: 0.0% C: 0.0%
AZN | News | $70.905 0.08% 1.6M |

Health Technology

| 12.37% | O: 0.38% H: 2.31% C: 2.02%
report business global growth

---

Global Acute Myeloid Leukemia (AML) Treatment Market Trends Analysis Report 2023-2028 - Personalized Medicine and Patient Advocacy Drive Opportunities
Published: 2023-10-20 (Crawled : 10:00) - prnewswire.com
ALPMF | News | $9.5 1.2K |

Health Technology

| -27.09% | O: -4.45% H: 0.0% C: 0.0%
SNYNF | News | $94.25 480 |

Health Technology

| -12.95% | O: -3.95% H: 0.0% C: -0.72%
ALPMY | News | $9.49 480K |

Manufacturing

| -23.9% | O: -2.89% H: 3.67% C: 2.85%
GSK | News | $40.82 -1.02% 230K |

Health Technology

| 16.53% | O: 0.42% H: 0.54% C: 0.11%
SNY | News | $47.27 -0.88% 130K |

Health Technology

| -10.26% | O: -0.17% H: 0.0% C: 0.0%
AMGN | News | $273.905 0.13% 270K |

Health Technology

| -2.52% | O: 0.0% H: 0.16% C: -0.64%
report treatment global trends leukemia market

---

Doxorubicin Market size to grow by USD 469.97 million from 2022 to 2027, North America to account for 47% of market growth- Technavio
Published: 2023-10-19 (Crawled : 03:00) - prnewswire.com
NVS | News | $98.03 0.77% 650K |

Health Technology

| 2.87% | O: -0.19% H: 0.0% C: -1.33%
BAX | $40.745 -0.67% 150K |

Health Technology

| 27.95% | O: -0.09% H: 3.78% C: 1.81%
america doxorubicin market

---

Gainers vs Losers

67%

33%

Top 10 Gainers

CZOO | $11.44 129.26% 4.6M |

AMST | $3.4 70.0% 51M |

Technology Services

BOF | $1.78 52.14% 15M |

SYRA | $1.5 51.23% 1M |

n/a

CSSE 4 | $0.23 51.02% 46M |

Consumer Services

RILY | $30.87 42.13% 7.8M |

Finance

LICN | $0.76 35.71% 6.2M |

TROO | $1.41 29.36% 280K |

Manufacturing

MULN | News | $3.53 29.3% 4.8M |

Information

RBBN 4 | $3.26 26.85% 1.2M |

Electronic Technology

---

Your saved searches

---